2/17 Late treatment study
Sun, Y., deputy head of the China National Center for Biotechnology Development (News) (not included in the study count)
Antimalarial drug confirmed effective on COVID-19
HCQ under clinical trials in >10 hospitals in China and has shown fairly good efficacy.
Sun et al., 2/17/2020, preprint, 1 author.
Please send us corrections, updates, or comments.
Submit